Attached files

file filename
EX-32.2 - EX-32.2 - Krystal Biotech, Inc.krys-ex322_10.htm
EX-32.1 - EX-32.1 - Krystal Biotech, Inc.krys-ex321_7.htm
EX-31.2 - EX-31.2 - Krystal Biotech, Inc.krys-ex312_11.htm
EX-31.1 - EX-31.1 - Krystal Biotech, Inc.krys-ex311_9.htm
EX-23.1 - EX-23.1 - Krystal Biotech, Inc.krys-ex231_8.htm
EX-10.16 - EX-10.16 ASTRA LEASE - Krystal Biotech, Inc.krys-ex1016_82.htm
EX-10.15 - EX-10.15 WHARTON LEASE 5TH AMENDMENT - Krystal Biotech, Inc.krys-ex1015_81.htm
EX-10.14 - EX-10.14 WHARTON LEASE 4TH AMENDMENT - Krystal Biotech, Inc.krys-ex1014_79.htm
EX-10.13 - EX-10.13 WHARTON LEASE 3RD AMENDMENT - Krystal Biotech, Inc.krys-ex1013_80.htm
EX-4.3 - EX-4.3 DESCRIPTION OF COMMON STOCK - Krystal Biotech, Inc.krys-ex43_128.htm
10-K - 10-K - Krystal Biotech, Inc.krys-10k_20191231.htm

Exhibit 21.1

SUBSIDIARIES OF KRYSTAL BIOTECH, INC. AS OF DECEMBER 31, 2019

 

Name

 

Direct Parent

 

Ownership

 

 

Jurisdiction of Incorporation

Krystal Australia Pty Ltd

 

Krystal Biotech, Inc.

 

100%

 

 

Australia

Jeune, Inc.

 

Krystal Biotech, Inc.

 

100%

 

 

Delaware